U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904105) titled 'A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity' on March 25.
Brief Summary: The study is being conducted to evaluate the efficacy and safety of HRS-7535 in subjects with overweight or obesity.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: HRS-7535 Tablets
HRS-7535 tablets.
DRUG: HRS-7535 Placebo Tablets
HRS-7535 placebo tablets.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....